Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Schwimmer, Jeffrey B ^a,b,c   Zepeda, Anne ^a,d   Newton, Kimberly P ^a,b   Xanthakos, Stavra A ^e   Behling, Cynthia ^f   Hallinan, Erin K ^g   Donithan, Michele ^g   Tonascia, James ^g  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f Sharp Fertility Center   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID; INSULIN;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; STEATOSIS; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; BLOOD; BLOOD PRESSURE MEASUREMENT; CHI SQUARE DISTRIBUTION; COMPLICATION; FATTY LIVER; NATIONAL HEALTH ORGANIZATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PRESCHOOL CHILD; PROCEDURES; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADOLESCENT; BLOOD PRESSURE DETERMINATION; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, LDL; COHORT STUDIES; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; INSULIN; LOGISTIC MODELS; MALE; NATIONAL INSTITUTES OF HEALTH (U.S.); NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; URIC ACID;

EID: 84912574980     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112569     Document Type: Article

References (43)

1. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, et al. (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118: 1388-1393.
2. Din-Dzietham R, Liu Y, Bielo MV, Shamsa F (2007) High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation 116: 1488-1496.
3. Rosner B, Cook NR, Daniels S, Falkner B (2013) Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008. Hypertension 62: 247-254.
4. Bao W, Threefoot SA, Srinivasan SR, Berenson GS (1995) Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens 8: 657-665.
5. Chen X, Wang Y (2008) Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation 117: 3171-3180.
6. Hartiala O, Magnussen CG, Kajander S, Knuuti J, Ukkonen H, et al. (2012) Adolescence risk factors are predictive of coronary artery calcification at middle age: the cardiovascular risk in young Finns study. J Am Coll Cardiol 60: 1364-1370.
7. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, et al. (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44: 865-873.
8. Pacifico L, Cantisani V, Ricci P, Osborn JF, Schiavo E, et al. (2008) Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 63: 423-427.
9. Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S (2008) Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 118: 277-283.
10. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, et al. (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121.
11. Ong JP, Pitts A, Younossi ZM (2008) Increased overall mortality and liver-related mortality in nonalcoholic fatty liver disease. J Hepatol 49: 608-612.
12. Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, et al. (2010) Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol 105: 2093-2102.
13. Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, et al. (2008) Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 32: 381-387.
14. Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, et al. (2011) Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 305: 1659-1668.
15. Patton HM, Lavine JE, Van Natta ML, Schwimmer JB, Kleiner D, et al. (2008) Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology 135: 1961-1971.e1962.
16. Schwimmer JB, Newton KP, Awai HI, Choi LJ, Garcia MA, et al. (2013) Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther 38: 1267-1277.
17. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.
18. U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114: 555-576.
19. Acosta AA, Samuels JA, Portman RJ, Redwine KM (2012) Prevalence of persistent prehypertension in adolescents. J Pediatr 160: 757-761.
20. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, et al. (2007) Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 150: 640-644, 644.e641.
21. Obarzanek E, Wu CO, Cutler JA, Kavey RE, Pearson GD, et al. (2010) Prevalence and incidence of hypertension in adolescent girls. J Pediatr 157: 461-467, 467.e461-465.
22. Pacifico L, Di Martino M, De Merulis A, Bezzi M, Osborn JF, et al. (2014) Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Hepatology 59: 461-470.
23. Singh GK, Vitola BE, Holland MR, Sekarski T, Patterson BW, et al. (2013) Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. J Pediatr 162: 1160-1168, 1168.e1161.
24. Apovian CM, Bigornia S, Mott M, Meyers MR, Ulloor J, et al. (2008) Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 28: 1654-1659.
25. Stanton MC, Chen SC, Jackson JV, Rojas-Triana A, Kinsley D, et al. (2011) Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. J Inflamm (Lond) 8: 8.
26. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, et al. (2005) Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 42: 473-480.
27. Dharmashankar K, Widlansky ME (2010) Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep 12: 448-455.
28. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, et al. (2004) Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 109: 613-619.
29. Pasarín M, La Mura V, Gracia-Sancho J, García-Calderó H, Rodríguez-Vilarrupla A, et al. (2012) Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. PLoS One 7: e32785.
30. Sander M, Chavoshan B, Victor RG (1999) A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33: 937-942.
31. Balligand JL (2002) New mechanisms of LDL-cholesterol induced endothelial dysfunction; correction by statins. Bull Mem Acad R Med Belg 157: 427-431; discussion 431-424.
32. Woodman RJ, Watts GF, Playford DA, Best JD, Chan DC (2005) Oxidized LDL and small LDL particle size are independently predictive of a selective defect in microcirculatory endothelial function in type 2 diabetes. Diabetes Obes Metab 7: 612-617.
33. Catar RA, Müller G, Heidler J, Schmitz G, Bornstein SR, et al. (2007) Low-density lipoproteins induce the renin-angiotensin system and their receptors in human endothelial cells. Horm Metab Res 39: 801-805.
34. Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F (2006) Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 17: 1466-1471.
35. Park JH, Jin YM, Hwang S, Cho DH, Kang DH, et al. (2013) Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: a mechanism for uric acid-induced cardiovascular disease development. Nitric Oxide 32: 36-42.
36. Vos MB, Colvin R, Belt P, Molleston JP, Murray KF, et al. (2012) Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr 54: 90-96.
37. Viazzi F, Antolini L, Giussani M, Brambilla P, Galbiati S, et al. (2013) Serum uric acid and blood pressure in children at cardiovascular risk. Pediatrics 132: e93-99.
38. Alper AB, Chen W, Yau L, Srinivasan SR, Berenson GS, et al. (2005) Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 45: 34-38.
39. McGill HC, McMahan CA, Zieske AW, Tracy RE, Malcom GT, et al. (2000) Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 102: 374-379.
40. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252.
41. Sanyal AJ, Banas C, Sargeant C, Luketic VA, Sterling RK, et al. (2006) Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 43: 682-689.
42. Sun SS, Grave GD, Siervogel RM, Pickoff AA, Arslanian SS, et al. (2007) Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics 119: 237-246.
43. Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, et al. (2014) Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension 63: 1116-1135.